Vanguard Group Inc Artivion, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,664,855 shares of AORT stock, worth $68.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,664,855
Previous 2,630,873
1.29%
Holding current value
$68.4 Million
Previous $47 Million
19.87%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AORT
# of Institutions
151Shares Held
34.8MCall Options Held
18KPut Options Held
1.5K-
Black Rock Inc. New York, NY6.74MShares$173 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.8MShares$71.8 Million0.07% of portfolio
-
Perceptive Advisors LLC New York, NY2.67MShares$68.5 Million1.19% of portfolio
-
Morgan Stanley New York, NY2.34MShares$59.9 Million0.0% of portfolio
-
Juniper Investment Company, LLC New York, NY2.1MShares$53.8 Million22.76% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.03B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...